475 filings
Page 11 of 24
8-K
MYMD
MyMD Pharmaceuticals Inc
27 Jul 20
Departure of Directors or Certain Officers
12:00am
PRER14A
MYMD
MyMD Pharmaceuticals Inc
Preliminary revised proxy
23 Jul 20
4:28pm
CORRESP
MYMD
MyMD Pharmaceuticals Inc
23 Jul 20
Correspondence with SEC
12:00am
8-K
MYMD
MyMD Pharmaceuticals Inc
22 Jul 20
Departure of Directors or Certain Officers
5:15pm
UPLOAD
MYMD
MyMD Pharmaceuticals Inc
22 Jul 20
Letter from SEC
12:00am
CORRESP
MYMD
MyMD Pharmaceuticals Inc
21 Jul 20
Correspondence with SEC
12:00am
UPLOAD
MYMD
MyMD Pharmaceuticals Inc
20 Jul 20
Letter from SEC
12:00am
PRE 14A
MYMD
MyMD Pharmaceuticals Inc
Preliminary proxy
13 Jul 20
5:10pm
8-K
MYMD
MyMD Pharmaceuticals Inc
13 Jul 20
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
8:01am
8-K
MYMD
MyMD Pharmaceuticals Inc
8 Jul 20
Akers Biosciences and Premas Biotech Announce Initiation of Animal Studies
11:48am
EFFECT
MYMD
MyMD Pharmaceuticals Inc
15 Jun 20
Notice of effectiveness
12:16am
CORRESP
MYMD
MyMD Pharmaceuticals Inc
10 Jun 20
Correspondence with SEC
12:00am
S-3/A
MYMD
MyMD Pharmaceuticals Inc
Shelf registration (amended)
5 Jun 20
4:40pm
CORRESP
MYMD
MyMD Pharmaceuticals Inc
5 Jun 20
Correspondence with SEC
12:00am
UPLOAD
MYMD
MyMD Pharmaceuticals Inc
2 Jun 20
Letter from SEC
12:00am
SC 13G
Intracoastal Capital, LLC
26 May 20
Akers Biosciences / INTRACOASTAL CAPITAL ownership change
6:23am
S-3
MYMD
MyMD Pharmaceuticals Inc
Shelf registration
22 May 20
5:01pm
D
MYMD
MyMD Pharmaceuticals Inc
21 May 20
$482.5K in options / securities to be acquired, sold $482.5K, 4 investors
3:01pm
8-K
MYMD
MyMD Pharmaceuticals Inc
19 May 20
Akers Biosciences Closes $4.8 Million Registered Direct Offering
12:00am
8-K
MYMD
MyMD Pharmaceuticals Inc
18 May 20
Other Events
6:14am